UTI extends 10 million USD facility loan to subsidiary UTI VINA amid subsidiary's negative equity and heavy losses, raising financial health concerns

UTI decided to extend the maturity of its existing 10 million USD loan to subsidiary UTI VINA by three years until 2029.
The loan is for facility funding at an interest rate of 4.6 percent, increasing the total loan balance to 38.3925 billion KRW.
As of 2025, UTI VINA had total assets of 56.439 billion KRW against total liabilities of 57.251 billion KRW, resulting in negative equity and a net loss of 17.192 billion KRW, indicating a weak financial structure.
This extension does not involve new capital injection and has no dilutive effect on shares, but persistent poor performance of the subsidiary could pressure UTI's consolidated financial statements.
[AI Summary]UTI extended a large loan to a subsidiary with negative equity, increasing credit risk. While no immediate dilution occurs, financial instability may negatively impact consolidated earnings, warranting investor caution.